Skip to content
Screener

Beta Bionics BBNX Q3 2026 earnings

Reported October 27, 2026 · After market close

Revenue$35.5MBeat by $783.8K
EPS-$0.52Beat by $0.00
Revenue estimate$34.7M
EPS estimate-$0.52

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$35.5M+30.3%
Gross profit$20.3M+34.5%
Operating income-$26.6M-56.1%
Net income-$24.4M-71.4%
EPS (diluted)-$0.52-57.6%

Balance sheet

See full
Cash & equivalents$81.6M+112%
Total debt$6.1M-20.6%
Total equity$401.4M+36.2%
Total assets$443.8M+34.5%

Cash flow

See full
Operating cash flow-$12.3M-40.8%
CapEx$2.3M+77.5%
Free cash flow-$14.6M-45.5%

Valuation & ratios

Valuation

as of 10/27/26
See full
Market cap$1.03B+7.2%
Enterprise value$958.16M+2.9%
P/S8.1×-2.8×

Profitability

See full
Gross margin58.6%+4.1pp
Operating margin-72.7%-4.2pp
Net margin-65.3%-13.3pp
FCF margin-51.8%-10.1pp

Returns & leverage

See full
Return on equity-23.9%—
Debt / equity0×0.0×
Current ratio8.9×-1.7×

Segments

By product

See full
Single Use Products$13.6M+99.5%
I Let$11.6M-18.4%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q3 2026 earnings?
Beta Bionics (BBNX) reported Q3 2026 earnings on October 27, 2026 after market close.
What were Beta Bionics's Q3 2026 revenue and EPS?
Beta Bionics reported revenue of $35.5M and eps of $-0.52 for Q3 2026.
Did Beta Bionics beat estimates in Q3 2026?
Revenue beat the consensus estimate of $34.7M by $783.8K. EPS beat the consensus estimate of $-0.52 by $0.00.
How did Beta Bionics's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 30.3% from $27.3M a year earlier and eps declined 57.6% from $-0.33.
Where can I find Beta Bionics's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-006856) and the 10-Q periodic report (0001674632-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.